×




The Novartis Malaria Initiative Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for The Novartis Malaria Initiative case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. The Novartis Malaria Initiative case study is a Harvard Business School (HBR) case study written by Michael Chu, Vincent Dessain, Emilie Billaud. The The Novartis Malaria Initiative (referred as “Malaria Novartis” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, Social enterprise, Social responsibility, Strategy.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of The Novartis Malaria Initiative Case Study


The Novartis Malaria Initiative was designed, as a result of a precedent-setting agreement with the World Health Organization in 2001, to provide a breakthrough treatment for malaria-"at no profit"-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of the anti-malarial drug Coartem A?. But with the significantly increased volumes came increased costs, bringing into question the sustainability of the program. In 2013, Dr. Linus Igwemezie, executive vice president and head of the Novartis Malaria Initiative, reflected on the evolution of the program and the way forward. His goal was to expand access to Coartem in the private sector through a low-margin, high-volume social business model to eventually enable the Malaria Initiative to break even and become financially sustainable. Was this the right strategy?


Case Authors : Michael Chu, Vincent Dessain, Emilie Billaud

Topic : Strategy & Execution

Related Areas : Social enterprise, Social responsibility, Strategy




Calculating Net Present Value (NPV) at 6% for The Novartis Malaria Initiative Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10023141) -10023141 - -
Year 1 3472566 -6550575 3472566 0.9434 3276006
Year 2 3954325 -2596250 7426891 0.89 3519335
Year 3 3939650 1343400 11366541 0.8396 3307806
Year 4 3236491 4579891 14603032 0.7921 2563604
TOTAL 14603032 12666751




The Net Present Value at 6% discount rate is 2643610

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Net Present Value
3. Payback Period
4. Internal Rate of Return

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Malaria Novartis shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Malaria Novartis have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of The Novartis Malaria Initiative

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Malaria Novartis often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Malaria Novartis needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10023141) -10023141 - -
Year 1 3472566 -6550575 3472566 0.8696 3019623
Year 2 3954325 -2596250 7426891 0.7561 2990038
Year 3 3939650 1343400 11366541 0.6575 2590384
Year 4 3236491 4579891 14603032 0.5718 1850474
TOTAL 10450518


The Net NPV after 4 years is 427377

(10450518 - 10023141 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10023141) -10023141 - -
Year 1 3472566 -6550575 3472566 0.8333 2893805
Year 2 3954325 -2596250 7426891 0.6944 2746059
Year 3 3939650 1343400 11366541 0.5787 2279890
Year 4 3236491 4579891 14603032 0.4823 1560808
TOTAL 9480562


The Net NPV after 4 years is -542579

At 20% discount rate the NPV is negative (9480562 - 10023141 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Malaria Novartis to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Malaria Novartis has a NPV value higher than Zero then finance managers at Malaria Novartis can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Malaria Novartis, then the stock price of the Malaria Novartis should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Malaria Novartis should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What can impact the cash flow of the project.

What will be a multi year spillover effect of various taxation regulations.

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of The Novartis Malaria Initiative

References & Further Readings

Michael Chu, Vincent Dessain, Emilie Billaud (2018), "The Novartis Malaria Initiative Harvard Business Review Case Study. Published by HBR Publications.


Hokushin Co Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Constr. - Supplies & Fixtures


Shindaeyang Pa SWOT Analysis / TOWS Matrix

Basic Materials , Paper & Paper Products


Tod’s SWOT Analysis / TOWS Matrix

Consumer Cyclical , Footwear


Metabiomed SWOT Analysis / TOWS Matrix

Healthcare , Medical Equipment & Supplies


Rio Tinto ADR SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Parkd SWOT Analysis / TOWS Matrix

Services , Business Services


Scottish Mortgage SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


First-Corporation SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Actinogen Medical SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs